Shannon Hall's most recent trade in Mesa Laboratories, Inc. was a trade of 2,784 Restricted Stock Units - 8 done . Disclosure was reported to the exchange on Aug. 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 2,784 | 2,784 | - | - | Restricted Stock Units - 8 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 1,404 | 0 | - | - | Restricted Stock Units - 7 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2025 | 1,404 | 4,189 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,074 | 2,785 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,074 | 0 | - | - | Restricted Stock Units - 6 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 1,404 | 1,404 | - | - | Restricted Stock Units - 7 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 754 | 0 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 754 | 1,711 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Sale of securities on an exchange or to another person at price $ 174.97 per share. | 08 Dec 2022 | 230 | 957 (0%) | 0% | 175.0 | 40,244 | Common Stock |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 431 | 1,187 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 431 | 0 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 754 | 754 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 431 | 431 | - | - | Restricted Stock Units - 4 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 0 | - | - | Restricted Stock Units - 3 | |
| Mesa Laboratories, Inc. | Shannon M. Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 308 | 756 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2020 | 308 | 308 | - | - | Restricted Stock Unit - 3 | |
| Mesa Laboratories, Inc. | Shannon Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 254 | 254 (0%) | 0% | 0 | Common Stock | |
| Mesa Laboratories, Inc. | Shannon Hall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2020 | 254 | 0 | - | - | Restricted Stock Units - 1 |